Holen Sie sich die Stockscreener-App
1.45
4.61%
-0.07
Handel nachbörslich:
1.47
0.02
+1.38%
Schlusskurs vom Vortag:
$1.52
Offen:
$1.52
24-Stunden-Volumen:
258.28K
Relative Volume:
0.74
Marktkapitalisierung:
$54.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.84%
1M Leistung:
-17.14%
6M Leistung:
-22.87%
1J Leistung:
-39.33%
1-Tages-Spanne:
$1.44
$1.54
1-Wochen-Bereich:
$1.39
$1.59
52-Wochen-Spanne:
$1.23
$3.95
Metagenomi Therapeutics Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Therapeutics Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Compare MGX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Therapeutics Inc
|
1.45 | 57.07M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Metagenomi Therapeutics Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Therapeutics Inc Aktie (MGX) Neueste Nachrichten
Is Metagenomi Therapeutics (NASDAQ:MGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Analysis: Acusphere (OTCMKTS:ACUS) and Metagenomi (NASDAQ:MGX) - Defense World
Xeris Biopharma (NASDAQ:XERS) and Metagenomi (NASDAQ:MGX) Critical Comparison - Defense World
Metagenomi (NASDAQ:MGX) and UCB (OTCMKTS:UCBJY) Critical Survey - Defense World
These two noteworthy penny stocks can do wonders! Here's more insights into Alto Ingredients, Metagenomi and others - MSN
Aug Sentiment: Why Metagenomi Inc stock could benefit from AI revolutionAnalyst Upgrade & Daily Volume Surge Trade Alerts - moha.gov.vn
Resistance Check: Should I add Metagenomi Inc stock to my portfolioJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Metagenomi changes name, advances hemophilia A gene therapy program By Investing.com - Investing.com Nigeria
Metagenomi advances gene editing therapies into 2025 - MSN
Metagenomi changes name, advances hemophilia A gene therapy program - Investing.com
Metagenomi Therapeutics Rebrands to Emphasize Therapeutic Focus - TipRanks
Metagenomi to submit IND in Q4 2026 to advance MGX-001 into first human studies - TipRanks
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - The Manila Times
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights ... - bdtonline.com
Gainers Report: Is Metagenomi Inc stock dividend yield sustainableFed Meeting & Weekly Top Performers Watchlists - moha.gov.vn
Is Metagenomi Inc. stock dividend yield sustainableWide Width Options & HOKA model picks for your routine - ulpravda.ru
Operating cash flow per share of Metagenomi, Inc. – NASDAQ:MGX - TradingView — Track All Markets
VIX Spike: Is Metagenomi Inc. stock dividend yield sustainableTrend Reversal & Expert Curated Trade Setups - Улправда
Patterns Watch: Is Metagenomi Inc. stock undervalued vs historical averages2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Is Metagenomi Inc. stock positioned well for digital economy2025 Stock Rankings & AI Forecasted Entry and Exit Points - Улправда
Is Metagenomi Inc. stock a defensive play in 2025Earnings Miss & Weekly High Momentum Picks - Улправда
Will Metagenomi Inc. stock attract ESG investors2025 Short Interest & Free AI Powered Buy and Sell Recommendations - Улправда
How interest rate cuts could boost Metagenomi Inc. stock2025 Trading Volume Trends & High Accuracy Investment Entry Signals - ulpravda.ru
Market Overview: Is Metagenomi Inc. stock supported by innovation pipelineWeekly Profit Summary & Expert-Curated Trade Recommendations - ulpravda.ru
Is Metagenomi Inc. stock in correction or buying zoneWeekly Investment Report & Capital Efficiency Focused Ideas - Улправда
Oklahoma City NewsThe OklahomanMetagenomi, Inc.Common Stock (Nasdaq:MGX) Detailed Stock Data - FinancialContent
Is Metagenomi Inc. stock supported by innovation pipelineAnalyst Upgrade & Entry Point Confirmation Alerts - ulpravda.ru
Why Metagenomi Inc. stock attracts global investorsJuly 2025 Summary & Long-Term Capital Growth Ideas - ulpravda.ru
Why Cloudflare, Inc. stock attracts strong analyst attention - Улправда
Is Metagenomi Inc. stock attractive after correctionHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - Улправда
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Aug Fed Impact: Is Metagenomi Inc stock undervalued vs historical averagesCEO Change & Reliable Breakout Forecasts - moha.gov.vn
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Head to Head Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Metagenomi (NASDAQ:MGX) - Defense World
Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1% - Defense World
Exit Recap: Is Metagenomi Inc stock supported by innovation pipeline2025 Trading Volume Trends & Fast Moving Stock Trade Plans - moha.gov.vn
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com UK
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
Metagenomi Earnings Notes - Trefis
CEO Moves: Can Metagenomi Inc stock weather global recession2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
Why analysts upgrade Metagenomi Inc. stock2025 Price Targets & High Win Rate Trade Alerts - Улправда
Is Metagenomi Inc. stock recession proofJuly 2025 Summary & High Accuracy Investment Entry Signals - Улправда
Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock - Investing.com India
Metagenomi CFO Wapnick sells $2792 in shares By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock By Investing.com - Investing.com Australia
Metagenomi general counsel Wein sells $352 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock - Investing.com
Finanzdaten der Metagenomi Therapeutics Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Therapeutics Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):